3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
2
Sponsor Class
OTHER_GOV
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
17
Other solid neoplasm
4
Gynecologic
3
Gastrointestinal
3
Endocrine
2
Sarcoma
1
NET
1
Head & Neck
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Neuroendocrine Tumors
69
Carcinoma, Neuroendocrine
26
Pheochromocytoma
23
Thyroid Cancer, Papillary
21
Pituitary Neoplasms
21
Thyroid Neoplasms
20
Adrenocortical Carcinoma
18
Paraganglioma
15
Multiple Endocrine Neoplasia Type 1
12
Sarcoma
11
Neuroblastoma
11
Small Cell Lung Carcinoma
10
Neoplasms
10
Melanoma
9
Lung Neoplasms
9
Carcinoid Tumor
9
Adrenal Gland Neoplasms
9
Adenoma, Islet Cell
9
Pancreatic Neoplasms
8
Gastro-enteropancreatic neuroendocrine tumor
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Medullary
8
Adenocarcinoma, Follicular
8
Thyroid Carcinoma, Anaplastic
7
Ovarian Neoplasms
7
Neoplasm Metastasis
7
Cushing Syndrome
7
Cholangiocarcinoma
7
Central Nervous System Neoplasms
7
Breast Neoplasms
7
Interventions
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Thymoma
×
Endocrine
×
90 days
×
Clear all
NCT04375267
2026-04-14
LuPARP
Vastra Gotaland Region
Phase 1
Completed
18 enrolled
NCT05461430
2026-04-13
TraveraRTGx
Travera Inc
Completed
72 enrolled